KBC

ClimateCamp is a developer of a greenhouse gas accounting platform aimed at de-carbonizing supply chains. The platform provides detailed information on carbon emissions throughout the supply chain, enabling companies to gain a comprehensive view of their carbon footprint. By facilitating collaboration among key stakeholders, ClimateCamp offers up-to-date insights into emissions, allowing businesses to efficiently target their reduction efforts.

Elis is a multi-services group operating in Europe and Brazil, specializing in the rental and maintenance of professional clothing, flat linen, and hygiene appliances. The company provides a wide range of tailored solutions, including services for washrooms, floor protection, beverages, cleanrooms, pest control, and medical waste management. With over 19,000 employees across 13 countries, Elis serves more than 240,000 businesses in various sectors, including hospitality, healthcare, industry, retail, and services. The company's extensive network of nearly 300 production and distribution centers, alongside 13 clean rooms, enables it to maintain strong proximity to its clients and deliver high-quality services efficiently. With over a century of experience, Elis has established itself as a leader in cleanliness, image, hygiene, and well-being services.

MICLEDI Microdisplays BV specializes in designing and manufacturing micro light-emitting diode (microLED) display chips tailored for augmented reality (AR) glasses. Based in Leuven, Belgium, the company operates as a fabless developer, focusing on advanced technology that integrates III/V materials processing, 3D integration, and 300mm silicon-based processing. MICLEDI's proprietary application-specific integrated circuit (ASIC) enables the production of compact, monolithic AR displays that deliver high image quality and enhanced power efficiency. By providing microLED display modules on wafers, MICLEDI serves the semiconductor industry, contributing to the advancement of AR technology.

Discai is a subsidiary of KBC Group that specializes in providing innovative artificial intelligence solutions tailored for financial service providers. By commercializing KBC's in-house developed applications, Discai aims to set new standards in the fintech industry. The company offers a digital platform that delivers reliable AI-driven tools, enabling financial institutions to streamline their operations and focus on their primary objectives. Through a Bank/Insurance-as-a-Service model, Discai gradually releases its applications to make advanced technology accessible to various players in the financial sector. This approach allows businesses to adapt to evolving technological and regulatory demands while unburdening their financial ecosystems.

Settle is a real estate application that aims to enhance the home renovation process by providing clients with tools to optimize their budgets and make informed decisions. The platform supports users during the pre-purchase phase by offering insights on price tags, renovation estimates, and local vacancies, facilitating a smoother home buying experience. Additionally, Settle fosters collaboration by connecting digital files to payment, streamlining exchanges and providing built-in trust. As the professional community increasingly shifts to digital and remote collaboration, Settle addresses the shortcomings of traditional methods by offering a seamless and efficient solution for transferring digital work. The company's mission is to empower users to maximize their resources and improve transparency in the renovation process.

Unbox, founded in 2020 and headquartered in Antwerp, Belgium, specializes in creating closed-loop systems that facilitate the efficient and transparent distribution of funds. The company's innovative approach ensures that financial resources are directed precisely to their intended recipients, thereby enabling governments, brands, and non-profits to optimize their working capital. By eliminating issues such as leakage and slippage, Unbox enhances accountability and effectiveness in fund distribution, making it a valuable partner for organizations seeking to improve financial management and resource allocation.

Raiffeisenbank Bulgaria is a banking institution that offers a range of financial products and services tailored to both individual and corporate clients. It serves various customer segments, including individuals, micro and small enterprises, and larger institutional clients. The bank's offerings encompass retail and corporate banking services, investment solutions, mortgage lending, and credit and debit card services. Additionally, it provides savings accounts, loans, and insurance products, aiming to meet the diverse financial needs of its clientele.

Guud Woman is a platform dedicated to improving menstrual health for women by providing a range of natural supplements and support. The company offers products aimed at hormonal balance, fertility, and overall well-being, including serums and capsules for skin and hair health. By vertically integrating these resources, Guud Woman aims to empower women to take charge of their health and well-being through accessible and effective solutions tailored to their specific needs.

NN Group-Pension and life insurance businesses offer Life Insurance, Mandatory Pensions, and Voluntary Pensions.

Stellar Labs specializes in transforming workplace learning through its innovative AI-driven platform, which integrates neuroscience-based methodologies to enhance professional development. The company's offerings include a variety of open and customizable learning programs that blend digital training with interactive workshops, peer collaboration, and practical assignments. This approach aims to address the skills gap in the technology sector by ensuring efficient knowledge transfer and real-world application. Key features of the platform include rapid design and delivery of learning experiences, evidence-based training for improved knowledge retention, and adaptive learning paths that personalize education for each individual. Furthermore, Stellar Labs emphasizes measurable outcomes, providing insights into performance improvements and productivity gains within organizations. By fostering a dynamic learning culture, Stellar Labs equips teams with essential skills for the future, ultimately driving enhanced performance and productivity.

Wizata SA, founded in 2014 and based in Capellen, Luxembourg, specializes in developing platform-as-a-service solutions tailored for the manufacturing industry. The company's software focuses on enhancing quality control, maintenance, and overall performance within manufacturing processes. By leveraging artificial intelligence, Wizata provides tools that address critical areas such as production optimization, quality sustainability, and predictive maintenance. The company also caters to various sectors, including insurance, energy, healthcare, and e-commerce, aiming to uncover valuable insights from both internal and external data. Through collaboration with industry experts and data scientists, Wizata offers customized solutions to help clients navigate the complexities of their specific challenges and identify unexploited opportunities.

ArtiQ is an innovative spin-off from the University of Leuven, founded in early 2019 by a team with extensive experience in respiratory medicine, medical devices, and artificial intelligence. The company focuses on developing AI-backed software to support medical professionals in diagnosing, treating, and monitoring patients with lung diseases. By automating the interpretation of pulmonary function tests, ArtiQ's technology enhances the accuracy and efficiency of the diagnostic process, facilitating the early detection of disease patterns. This approach not only aids healthcare practitioners in making informed decisions but also aims to improve the overall environment for lung disease diagnostics, ultimately benefiting patients and the healthcare system. ArtiQ aspires to be a trusted partner for medical practitioners in addressing respiratory issues.

Joyn Belgium operates a customer engagement platform that enhances the relationship between merchants and their customers. The platform allows users to utilize a loyalty card that enables them to earn rewards points while shopping at their preferred stores. Customers can redeem these points for various benefits, including discounts and prizes, fostering loyalty and repeat business. By integrating the efforts of numerous local merchants, Joyn provides a unified app that offers unique advantages to customers, encouraging them to return to participating businesses. This approach not only supports merchants in growing their customer base but also helps consumers discover valuable rewards and promotions from a diverse range of local retailers.

United Bulgarian Bank is a financial institution based in Sofia, Bulgaria, offering a wide range of banking products and services to individual, microbusiness, and corporate clients. The bank provides various deposit options, including savings accounts, current accounts, and online deposits. In addition to its deposit services, United Bulgarian Bank offers an extensive array of loan products such as consumer loans, mortgage loans, and working capital loans, as well as specialized loans under European and guarantee programs. The bank also facilitates access to debit and credit cards and provides services in insurance, investment banking, mobile banking, and trade finance. Through its comprehensive offerings, the bank aims to deliver personalized banking solutions to meet the diverse needs of its clients.

Interlease is a Bulgarian leasing company that operates under the umbrella of the Belgian banking and insurance group KBC. It specializes in providing financing and leasing services for a variety of assets, including high-quality equipment, transportation vehicles, and office supplies. By enabling Bulgarian enterprises to acquire necessary resources, Interlease aims to enhance their competitiveness and market positions both locally and internationally. The company also emphasizes customer support after the delivery of assets by utilizing effective internet and mobile technologies, allowing clients to select their preferred suppliers and asset types that best fit their business needs.

Go Vocal is a digital community engagement platform that facilitates interaction between local governments and their communities. It provides a centralized tool for conducting surveys, ideation, participatory budgeting, deliberation, and information sharing. By employing artificial intelligence and natural language processing, Go Vocal transforms unstructured citizen input into actionable insights, allowing governments to analyze and moderate feedback effectively. The platform also generates automated reports that offer valuable insights for decision-making. Ultimately, Go Vocal aims to enhance the inclusiveness and responsiveness of governmental decisions by enabling efficient management of citizen ideas and real-time data analysis.

VB LEASING SK, spol. s r.o. is a leasing company based in Bratislava, Slovakia, specializing in the financing of movable objects. The company provides financial solutions for personal and utility vehicles, machinery, equipment, technology, and computing systems. It also offers credit financing options to both corporate and private clients. Established in 1994, VB LEASING SK operates through a network of 11 branches and collaborates with 90 dealers and agents, employing around 90 full-time staff. The company was previously known as LB-Leasing spol. s r.o. before rebranding in 2002 and is currently a subsidiary of CSOB Leasing, a.s.

Pronota NV is a Belgian company specializing in the development and commercialization of innovative diagnostics aimed at the early detection of life-threatening conditions, such as heart failure, pre-eclampsia, and sepsis. The company utilizes a proprietary protein biomarker diagnostics platform that is non-invasive and validated, focusing on enhancing patient care and addressing unmet medical needs. Founded in 2004 and based in Zwijnaarde, Belgium, Pronota has garnered support from prominent investors and a network of key opinion leaders in the medical field. The firm was previously known as Peakadilly NV before rebranding in 2006.

BIC specialises in assisting international investors in acquiring businesses, as well as local companies in attracting strategic partners, and can look back on a number of successfully completed M&A transactions. From one region to another, the value of the deals it works on varies between 10 and 200 million euros. Its business portfolio is spread evenly across the various regions in which the company operates. BIC targets midcaps and is a strong player in the financial services, consumer goods, retail, distribution and selected industrial sectors.

Biocartis SA, established in 2007 and headquartered in Lausanne, Switzerland, is a molecular diagnostics company specializing in developing diagnostic technology platforms for multiplexed detection of bio-analytes such as proteins, nucleic acids, and small molecules. The company focuses on integrated molecular and immunodiagnostics using its proprietary micro-technology platform, offering products like the Idylla system for oncology and infectious disease segments. These products aid in early detection, staging, treatment selection, and monitoring of diseases by analyzing bio-molecules associated with risk factors. Biocartis generates revenue primarily through product sales.

Argenx is a global immunology company based in the Netherlands, dedicated to enhancing the lives of individuals affected by severe autoimmune diseases and cancer. The company specializes in antibody engineering technology to develop treatments for rare autoimmune conditions. Its lead product, Vyvgart (efgartigimod), received initial approval in the United States in December 2021 for the treatment of generalized myasthenia gravis, followed by subsequent approvals in Europe and Japan in 2022. Through its innovative approaches, Argenx aims to address significant unmet medical needs in the field of immunology.

CymaBay Therapeutics is a clinical-stage biopharmaceutical company based in Newark, California, dedicated to developing therapies for liver and other chronic diseases with significant unmet medical needs. The company's lead product candidate, seladelpar, is a selective agonist of the peroxisome proliferator-activated receptor delta, which has completed Phase II clinical studies targeting conditions such as primary biliary cholangitis and sclerosing cholangitis, as well as nonalcoholic steatohepatitis. Additionally, CymaBay is developing MBX-2982, a selective oral G protein-coupled receptor agonist aimed at treating gut and liver diseases. The company also has a preclinical candidate, CB-001, which targets omega-3 fatty acid receptors. CymaBay has entered into development and licensing agreements with other pharmaceutical firms to explore treatments for metabolic diseases, including type 2 diabetes and gout. The company's commitment to advancing its pipeline reflects its focus on creating innovative medicines that can improve patient outcomes.

Argenx is a global immunology company based in the Netherlands, dedicated to enhancing the lives of individuals affected by severe autoimmune diseases and cancer. The company specializes in antibody engineering technology to develop treatments for rare autoimmune conditions. Its lead product, Vyvgart (efgartigimod), received initial approval in the United States in December 2021 for the treatment of generalized myasthenia gravis, followed by subsequent approvals in Europe and Japan in 2022. Through its innovative approaches, Argenx aims to address significant unmet medical needs in the field of immunology.

Pronota NV is a Belgian company specializing in the development and commercialization of innovative diagnostics aimed at the early detection of life-threatening conditions, such as heart failure, pre-eclampsia, and sepsis. The company utilizes a proprietary protein biomarker diagnostics platform that is non-invasive and validated, focusing on enhancing patient care and addressing unmet medical needs. Founded in 2004 and based in Zwijnaarde, Belgium, Pronota has garnered support from prominent investors and a network of key opinion leaders in the medical field. The firm was previously known as Peakadilly NV before rebranding in 2006.

Aristo Music NV develops selection and distribution techniques and technologies for digital music and provides music related services. The company also develops various Internet applications, which include a Web radio that consists of a musical database. It serves catering, retail, business, leisure, and government markets. The company is based in Heverlee, Belgium.

Okapi Sciences NV is a Belgium-based company focused on developing antiviral therapeutics for pets and livestock. It operates a proprietary platform dedicated to creating innovative treatments for significant viral diseases, with five candidates currently in clinical or development stages. The company specializes in addressing viral infections affecting pets, particularly through its work on feline herpes and feline immunodeficiency virus. Okapi Sciences is committed to advancing its pipeline of antiviral drugs while fostering strong relationships with academic institutions to enhance its research capabilities and technological advancements in veterinary medicine.

Istrobanka is a provider of retail and wholesale banking products and services for corporate and individual customers in Slovakia. The company offers deposit products, savings and investment accounts, loans, corporate finance, insurance products, payment cards, mutual funds, and mortgage loans.

Richelieu Finance is an investment management company.

Senzal is a privately held company that specializes in providing brokerage services. It operates as a security brokerage firm, facilitating the buying and selling of financial securities for its clients. By focusing on delivering tailored brokerage solutions, Senzal aims to meet the diverse needs of investors in the financial market. The company is dedicated to offering a reliable platform for transactions, ensuring a seamless experience for its users.

Ceres is a non-profit organization focused on promoting sustainability leadership among businesses and investors. Based in Boston, Massachusetts, it mobilizes a diverse network of stakeholders, including companies and public interest groups, to enhance the adoption of sustainable practices that contribute to a healthier economy. Ceres conducts research on various aspects of business sustainability, examining trends and responses within sectors such as insurance, banking, and electric utilities, particularly concerning climate change and emissions. The organization also emphasizes the importance of climate risk disclosure and fuel economy standards in its efforts to advocate for a more sustainable future.

Hipobroker is a financial services provider operating in Serbia and Montenegro, specializing in brokerage services. The company facilitates the buying and selling of shares in the private market, offering valuable information to support security portfolios. By focusing on these financial services, Hipobroker aims to assist clients in navigating investment opportunities within the region.

Swiss Capital S.A. is an investment brokerage services in Romania. The company serves institutional clients and high net worth individuals.

CymaBay Therapeutics is a clinical-stage biopharmaceutical company based in Newark, California, dedicated to developing therapies for liver and other chronic diseases with significant unmet medical needs. The company's lead product candidate, seladelpar, is a selective agonist of the peroxisome proliferator-activated receptor delta, which has completed Phase II clinical studies targeting conditions such as primary biliary cholangitis and sclerosing cholangitis, as well as nonalcoholic steatohepatitis. Additionally, CymaBay is developing MBX-2982, a selective oral G protein-coupled receptor agonist aimed at treating gut and liver diseases. The company also has a preclinical candidate, CB-001, which targets omega-3 fatty acid receptors. CymaBay has entered into development and licensing agreements with other pharmaceutical firms to explore treatments for metabolic diseases, including type 2 diabetes and gout. The company's commitment to advancing its pipeline reflects its focus on creating innovative medicines that can improve patient outcomes.

Romstal Leasing IFN is the largest independent leasing company in Romania, specializing in a range of leasing services for both personal and commercial vehicles. As of the end of 2006, the company held a 4.20% share of the Romanian leasing market, positioning it as a significant player in the sector. Its primary focus is on car leasing, which accounts for 43.30% of its financing activities. In addition to vehicle leasing, Romstal Leasing also offers leasing solutions for delivery vans, lorries, machinery, equipment, and real estate, catering to diverse customer needs across various industries.

DZI is an Insurance company in Bulgaria, offering a wide range of Life and Non-life Insurance products, as well as bankassurance.

KBC Equitas is a privately held company that operates a stock exchange and offers online brokerage services. It provides an online trading system that allows clients to trade various financial instruments, including investment funds, shares, equities, certificates, exchange-traded funds, treasury bills, and futures. Through its platform, KBC Equitas aims to facilitate wealth preservation and enrichment for its clients.

Movetis NV is a pharmaceutical company dedicated to the discovery, development, and commercialization of drugs targeting gastrointestinal (GI) disorders. The company addresses a range of conditions, including severe chronic constipation, ascites, and pediatric reflux, as well as severe GI motility disorders like refractory gastro-oesophageal reflux disease. Its lead product, Resolor, is specifically designed for the symptomatic treatment of chronic constipation in women, with ongoing research for its efficacy in males and children, as well as in cases of opioid-induced constipation and post-operative ileus. Movetis is also developing M0002, currently in Phase II trials for treating ascites, and M0003, which is set to enter Phase II development for symptomatic relief of heartburn and regurgitation in patients unresponsive to proton pump inhibitors. Additionally, the company has two prioritized compounds from its preclinical portfolio and maintains partnerships with universities in Ghent, Leuven, and Rotterdam. Founded in 2006, Movetis is based in Turnhout, Belgium.

Banco Urquijo specializes in advising and managing legal entities, such as insurance companies, mutual companies, provident societies, cooperatives, and trusts that administer third party assets.

Ablynx is a biopharmaceutical company focused on the discovery and development of Nanobodies®, a unique class of therapeutic proteins derived from single-domain antibody fragments. These innovative proteins are designed to address a variety of serious human diseases, including inflammation, hematology, oncology, and pulmonary conditions. Currently, Ablynx has around 25 projects in its pipeline, with five Nanobodies in clinical development. By combining the advantages of traditional antibodies and small chemical molecules, Ablynx aims to provide new therapeutic options that can significantly improve patient care and outcomes.

Pronota NV is a Belgian company specializing in the development and commercialization of innovative diagnostics aimed at the early detection of life-threatening conditions, such as heart failure, pre-eclampsia, and sepsis. The company utilizes a proprietary protein biomarker diagnostics platform that is non-invasive and validated, focusing on enhancing patient care and addressing unmet medical needs. Founded in 2004 and based in Zwijnaarde, Belgium, Pronota has garnered support from prominent investors and a network of key opinion leaders in the medical field. The firm was previously known as Peakadilly NV before rebranding in 2006.

K&H Bank is a banking institution based in Budapest, Hungary, offering a wide range of financial services. Established in 1987, it operates as a wholly owned subsidiary of KBC Bank. The bank serves both retail and corporate clients, providing services such as lending, digital banking, insurance, wealth management, advisory, and transaction services. Additionally, K&H Bank specializes in corporate finance, agricultural loans, leasing, and funding for local governments, positioning itself as a comprehensive provider of financial solutions in the region.

HSBC Dewaay SA is a privately held company offers private banking and trustee services. It services include cash management, discretionary portfolio management, and patrimonial advisory services.

Effectenbank Stroeve N.V. is a privately held company offers capital management, stockbroking, and investment advisory services.

Aurel Leven Gestion, an independent asset management company, old, which manages funds on behalf of private clients and institutional investors. Aurel Leven Gestion, of February 2005, Aurel Leven Gestion was acquired by KBL France Gestion.

Aballea Finance SA is a privately held company specializing in wealth management and real estate management. The firm offers a range of financial advisory services, including real estate consulting, tax assistance, investment management, and financial reporting. By focusing on these areas, Aballea Finance aims to provide comprehensive support to its clients in managing their financial and real estate needs effectively.

Almanij NV engages in banking, insurance, and investment activities; and the provision of specialized financial services.

CymaBay Therapeutics is a clinical-stage biopharmaceutical company based in Newark, California, dedicated to developing therapies for liver and other chronic diseases with significant unmet medical needs. The company's lead product candidate, seladelpar, is a selective agonist of the peroxisome proliferator-activated receptor delta, which has completed Phase II clinical studies targeting conditions such as primary biliary cholangitis and sclerosing cholangitis, as well as nonalcoholic steatohepatitis. Additionally, CymaBay is developing MBX-2982, a selective oral G protein-coupled receptor agonist aimed at treating gut and liver diseases. The company also has a preclinical candidate, CB-001, which targets omega-3 fatty acid receptors. CymaBay has entered into development and licensing agreements with other pharmaceutical firms to explore treatments for metabolic diseases, including type 2 diabetes and gout. The company's commitment to advancing its pipeline reflects its focus on creating innovative medicines that can improve patient outcomes.

Banca KBL Fumagalli Soldan S.p.A. offers corporate, retail and private and investment banking services. It provides financial services worldwide.

WARTA S.A., established in 1920, is one of the largest and oldest insurance companies in Poland, recognized for setting standards in the country's insurance market. Headquartered in Warsaw, the company operates as a reinsurance broker and provides a diverse range of insurance products. Its offerings include motor, property, personal, financial, and third-party liability insurance, catering to various customer needs and contributing to the overall stability of the Polish insurance sector.